Novo CEO pressed by Senate to chop rates of obesity, diabetes medication CEO Lars Fruergaard Jørgensen advised lawmakers the business would take into account new talks with insurers about the listing price ranges of Wegovy and copyright when they pledge to keep the medicines on their own formularies. Don't miss https://kethek.com/